‹ ›
MYP_008645
← PREVIOUS NEXT → BACK
Basic Information
P9
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Coronavirus ▸ Anti-SARS-CoV-2
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Membrane / Ion-channel modulation ▸ Sodium channel modulation ▸ Sodium channel inhibitor
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
27 amino acids
C152H231N33O47S
Standard
Sequence
SALEEQYKTFLDKFMHELEDLLYQLSL
Physicochemical Analysis
3304.72 Da
4.35
-4.44
-4.71
-0.1646
-0.30
0.63
0.05
55.82
104.81
0.1481
2980.00
2980.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1311.77
-6.99
44.0
45.0
113.0
233.0
5.0
28.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0011993 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2 Cytotoxic
The peptide proved to be devoid of cell toxicity on Vero-E6 and Calu-3 cells
PMID33580154 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/33580154/
RECORD: Rec_0095667 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antiviral Anti-SARS-CoV-2 Replication inhibition
SARS-CoV-2 | Vero-E6 cells
10 μM
% inhibition
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperHuman ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection. | Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O. | Commun Biol. 2021 Feb 12;4(1):197. | DOI:10.1038/s42003-021-01736-8 | PMID:33580154 PMID33580154 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/33580154/
RECORD: Rec_0137263 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2 Cytotoxic
PMID33580154 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/33580154/
RECORD: Rec_0288090 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
Amidation
Bio-Activity Profile
Antiviral Replication inhibition
inhibition of replication in Calu-3 cells
0.053 μM
IC50
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperHuman ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection. | Karoyan P, Vieillard V, Gómez-Morales L, Odile E, Guihot A, Luyt CE, Denis A, Grondin P, Lequin O. | Commun Biol. 2021 Feb 12;4(1):197. | DOI:10.1038/s42003-021-01736-8 | PMID:33580154 PMID33580154 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/33580154/
RECORD: Rec_0292453 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
ACE2-derived peptide
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
Bio-Activity Profile
Antiviral
Severe acute respiratory syndrome coronavirus 2
0.053 μM
IC50
PaperHuman ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection PMID33580154 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/33580154/
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2